Patents by Inventor Drew Smith

Drew Smith has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20260050851
    Abstract: Disclosed herein are techniques for computationally efficient scoring and prioritization of resources. A method can include receiving a data request for a resource assignment in an operational environment, retrieving a queue of candidate resources associated with the operational environment, generating a dynamic score for at least one candidate resource in the queue of candidate resources based at least in part on the received data request, updating a prioritized resource list based on the dynamic score for the at least one candidate resource, the prioritized resource list including a group of resources having respective dynamic scores, assigning a resource from the prioritized resource list that satisfies one or more assignment criteria based on the received data request, and returning instructions that cause the assigned resource to be executed.
    Type: Application
    Filed: October 27, 2025
    Publication date: February 19, 2026
    Inventors: Daniƫl Walet, Daniel Thomas Wintz, Noah James Garnier, Daniel Bolis, Kaitlyn Garifi, Drew Smith
  • Publication number: 20080278960
    Abstract: The present invention relates generally to illuminated ornamental and/or decorative sculptures and/or structures. More particularly, the present invention relates to an illuminated structure having a plurality of individual optical elements disposed thereon.
    Type: Application
    Filed: July 17, 2008
    Publication date: November 13, 2008
    Inventors: Drew Smith, Susan Haug
  • Publication number: 20070274071
    Abstract: The present invention relates generally to illuminated ornamental and/or decorative sculptures and/or structures. More particularly, the present invention relates to an illuminated structure having a plurality of individual optical elements disposed thereon.
    Type: Application
    Filed: May 24, 2006
    Publication date: November 29, 2007
    Inventors: Drew Smith, Susan Haug
  • Publication number: 20070134715
    Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO:2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
    Type: Application
    Filed: January 29, 2007
    Publication date: June 14, 2007
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Greg Biesecker, Sumedha Jayasena, Larry Gold, Drew Smith, Gary Kirschenheuter
  • Patent number: 7176295
    Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO:2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
    Type: Grant
    Filed: October 2, 2002
    Date of Patent: February 13, 2007
    Assignee: Gilead Sciences, Inc.
    Inventors: Gregory Biesecker, Sumeda Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter
  • Publication number: 20060088877
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Application
    Filed: December 6, 2005
    Publication date: April 27, 2006
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Publication number: 20030186231
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Application
    Filed: October 9, 2001
    Publication date: October 2, 2003
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Publication number: 20030077646
    Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO: 1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO: 2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
    Type: Application
    Filed: October 2, 2002
    Publication date: April 24, 2003
    Applicant: GILEAD SCIENCES, INC.
    Inventors: Greg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter
  • Patent number: 6465189
    Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl ketone (SEQ ID NO:2). This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
    Type: Grant
    Filed: June 29, 2000
    Date of Patent: October 15, 2002
    Assignee: Gilead Sciences, Inc.
    Inventors: Greg Biesecker, Sumedha Jayasena, Larry Gold, Drew Smith, Gary Kirschenheuter
  • Patent number: 6300074
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: October 4, 1999
    Date of Patent: October 9, 2001
    Assignee: Gilead Sciences, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 6083696
    Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl (SEQ ID NO:3) ketone. This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
    Type: Grant
    Filed: October 23, 1997
    Date of Patent: July 4, 2000
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Greg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary Kirschenheuter
  • Patent number: 5998142
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: August 21, 1997
    Date of Patent: December 7, 1999
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 5962219
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: October 5, 1999
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 5763595
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: June 5, 1995
    Date of Patent: June 9, 1998
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 5705337
    Abstract: This application provides methods for identifying nucleic acid ligands capable of covalently interacting with targets of interest. The nucleic acids can be associated with various functional units. The method also allows for the identification of nucleic acids that have facilitating activities as measured by their ability to facilitate formation of a covalent bond between the nucleic acid, including its associated functional unit, and its target.
    Type: Grant
    Filed: March 8, 1995
    Date of Patent: January 6, 1998
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Larry Gold, Bruce Eaton, Drew Smith, Matthew Wecker, Kirk Jensen
  • Patent number: 5683867
    Abstract: A method is described for generating blended nucleic acid ligands containing non-nucleic acid functional units. Specifically, a SELEX identified RNA ligand to the integrin gpIIbIIIa is conjugated to the peptide Gly-Arg-Gly-Asp-Thr-Pro (SEQ ID NO:1). This blended RNA ligand inhibits the biological activity of gpIIbIIIa with high specificity. Also described is a single-stranded DNA ligand to elastase coupled to N-methoxysuccinyl-Ala-Ala-Pro-Val-chloromethyl (SEQ ID NO:2) ketone. This elastase blended nucleic acid ligand inhibits the biological activity of elastase.
    Type: Grant
    Filed: April 28, 1994
    Date of Patent: November 4, 1997
    Assignee: NeXstar Pharmaceuticals, Inc.
    Inventors: Greg Biesecker, Sumedha D. Jayasena, Larry Gold, Drew Smith, Gary P. Kirschenheuter